Japan's Astellas to buy Audentes for $3 billion in gene therapy push

Japan's Astellas to buy Audentes for $3 billion in gene therapy push

Source: 
Reuters
snippet: 

Japan’s Astellas Pharma Inc (4503.T) has agreed to buy Audentes Therapeutics Inc (BOLD.O) for about $3 billion in cash as it seeks to make genetic medicines a key area of growth.